S
7.45
0.16 (2.19%)
| 前收盘价格 | 7.29 |
| 收盘价格 | 7.27 |
| 成交量 | 895,752 |
| 平均成交量 (3个月) | 1,344,913 |
| 市值 | 466,524,192 |
| 价格/销量 (P/S) | 11.20 |
| 股市价格/股市净资产 (P/B) | 1.02 |
| 52周波幅 | |
| 利润日期 | 29 Jul 2025 - 4 Aug 2025 |
| 营业利益率 (TTM) | -476.01% |
| 稀释每股收益 (EPS TTM) | -6.59 |
| 季度收入增长率 (YOY) | 78.00% |
| 总债务/股东权益 (D/E MRQ) | 2.89% |
| 流动比率 (MRQ) | 9.13 |
| 营业现金流 (OCF TTM) | -311.09 M |
| 杠杆自由现金流 (LFCF TTM) | -172.27 M |
| 资产报酬率 (ROA TTM) | -36.35% |
| 股东权益报酬率 (ROE TTM) | -63.53% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Sage Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
-0.9
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -3.0 |
| 平均 | -0.88 |
|
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 10.41% |
| 机构持股比例 | 86.12% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 12.00 (HC Wainwright & Co., 61.07%) | 保留 |
| 12.00 (Scotiabank, 61.07%) | 购买 | |
| 中 | 10.00 (34.23%) | |
| 低 | 6.00 (Wedbush, -19.46%) | 保留 |
| 平均值 | 9.50 (27.52%) | |
| 总计 | 1 购买, 3 保留 | |
| 平均价格@调整类型 | 7.16 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 12 Feb 2025 | 8.00 (7.38%) | 保留 | 7.16 |
| HC Wainwright & Co. | 12 Feb 2025 | 12.00 (61.07%) | 保留 | 7.16 |
| Scotiabank | 12 Feb 2025 | 12.00 (61.07%) | 购买 | 7.16 |
| Wedbush | 12 Feb 2025 | 6.00 (-19.46%) | 保留 | 7.16 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合